AI assistant
Sleep Number Corp — Director's Dealing 2020
Feb 26, 2020
33589_dirs_2020-02-26_c8dc2b92-f198-4d28-b6b5-c5926d8f6e7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sleep Number Corp (SNBR)
CIK: 0000827187
Period of Report: 2020-02-25
Reporting Person: Krishna Suresh (SVP Chief Ops SC Lean Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-25 | Common Stock | M | 8800 | $19.38 | Acquired | 61790 | Direct |
| 2020-02-25 | Common Stock | M | 3866 | $23.61 | Acquired | 65656 | Direct |
| 2020-02-25 | Common Stock | M | 2555 | $34.35 | Acquired | 68211 | Direct |
| 2020-02-25 | Common Stock | S | 15221 | $53.0043 | Disposed | 52990 | Direct |
| 2020-02-25 | Common Stock | S | 13600 | $53.3302 | Disposed | 39390 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | Employee Stock Option (Performance-based) | $19.38 | M | 8800 | Disposed | 2026-04-11 | Common Stock (8800) | Direct |
| 2020-02-25 | Employee Stock Option (Right to Buy) | $23.61 | M | 3866 | Disposed | 2027-03-21 | Common Stock (3866) | Direct |
| 2020-02-25 | Employee Stock Option (Right to Buy) | $34.35 | M | 2555 | Disposed | 2028-03-21 | Common Stock (2555) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. The 15,221 shares were sold in multiple transactions at prices between $53.00 and $53.08, inclusive. The 13,600 shares were sold in multiple transactions at prices between $53.25 and $53.47, inclusive. The reporting person will provide the SEC Staff, Sleep Number or any security holder of Sleep Number, upon request, full information regarding the number of shares sold at each separate price.
F2: This performance-based option grant was earned only if the stock price of Sleep Number's common stock remained at or above a specified level for at least 20 consecutive trading days and was subject to continuous employment with the company for three years from the date of grant. The option grant fully vested and became exercisable on 4/11/19.
F3: This option becomes exercisable with respect to 1/3rd of the shares on each of 3/21/18, 3/21/19 and 3/21/20.
F4: This option becomes exercisable with respect to 1/3 of the shares on each of 3/21/19, 3/21/20 and 3/21/21.